Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoimmune enteropathy: molecular concepts.

Frank M Ruemmele1, Nicole Brousse, Olivier Goulet

  • 1Pediatric Gastroenterology Unit, Department of Pediatrics, Necker-Enfants Malades Hospital, Paris, Université René Descartes, Paris V, France. frank.ruemmele@nck.ap-hop-paris.fr

Current Opinion in Gastroenterology
|February 11, 2005
PubMed
Summary

Autoimmune enteropathy (AIE) is linked to FOXP3 gene mutations affecting regulatory T-cells. New treatments like immunosuppressants and bone marrow transplants offer hope for managing this challenging pediatric condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IL-10-neutralising autoantibodies in paediatric-onset inflammatory bowel disease.

Gut·2026
Same author

Cyclic exclusive enteral nutrition in paediatric Crohn's disease - Authors' reply.

The lancet. Gastroenterology & hepatology·2026
Same author

From childhood to adulthood in chronic intestinal failure: A nationwide study.

Clinical nutrition (Edinburgh, Scotland)·2026
Same author

Histogenetic Classification Predicts Outcomes in 130 Adults With Chronic Intestinal Pseudo-Obstruction.

The American journal of gastroenterology·2026
Same author

Cyclic exclusive enteral nutrition versus partial enteral nutrition to maintain long-term drug-free remission in paediatric Crohn's disease (CD-HOPE): an open-label, endpoint-blinded, randomised controlled trial.

The lancet. Gastroenterology & hepatology·2026
Same author

Long-Term Outcome of Paediatric Crohn's Disease Patients With Deep Ulcerations at Diagnosis.

Acta paediatrica (Oslo, Norway : 1992)·2025

Area of Science:

  • Pediatric Gastroenterology
  • Immunology
  • Genetics

Background:

  • Autoimmune enteropathy (AIE) presents significant diagnostic and therapeutic challenges in pediatric gastroenterology.
  • Recent molecular insights are illuminating the pathophysiology of AIE.
  • This review focuses on novel molecular concepts, diagnostic advancements, and therapeutic strategies for AIE.

Purpose of the Study:

  • To review recent molecular discoveries in autoimmune enteropathy (AIE).
  • To discuss the implications of these discoveries for diagnosis and treatment.
  • To provide an updated perspective on managing AIE in pediatric patients.

Main Methods:

  • Review of current literature on AIE molecular genetics and immunology.
  • Analysis of the role of FOXP3 gene mutations and regulatory T-cell function.

Related Experiment Videos

  • Evaluation of emerging diagnostic markers and therapeutic approaches.

    • Main Results:

    • Mutations in the FOXP3 gene are identified as a primary defect in AIE, impacting regulatory T-cell homeostasis.
    • FOXP3 dysfunction leads to T-cell hyperactivation and autoimmune aggression, as observed in immune dysregulation, polyendocrinopathy autoimmune enteropathy X-linked (IPEX) syndrome.
    • Anti-enterocyte autoantibodies appear secondary, not primary disease drivers.
    • Defects in other regulatory factors may also contribute to AIE.

    Conclusions:

    • Profound immune dysregulation in AIE necessitates novel treatment strategies.
    • Tacrolimus and steroids show promise but may not ensure long-term remission.
    • Bone marrow transplantation is a potential curative option for refractory cases, though long-term outcomes require further validation.